Advances In The Application Of Click Chemistry In The Research Of Targeted Therapeutic Drugs

Authors

  • Yue Zhang Department of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou, China

DOI:

https://doi.org/10.62051/y0yezt68

Keywords:

Click chemistry; cancer; biomedical applications.

Abstract

Click chemistry has become an important tool in the research of targeted therapeutic drugs due to its high efficiency, specificity and mild reaction conditions. Cancer, as one of the major diseases that endanger human health, urgently needs more accurate and efficient treatment methods. Traditional targeted therapeutic methods have the problems of poor selectivity and easy to cause serious side effects, while click chemistry significantly improves the specificity and effect of treatment by efficiently connecting drugs with targeting ligands (such as antibodies, peptides, small molecules, etc.). Especially in the development of antibody-drug conjugates (ADCs) and nanodrug delivery systems, click chemistry not only optimizes the synthesis process, but also improves the stable release of drugs at the tumor site and reduces systemic toxicity. In addition, nanocarriers constructed based on click chemistry can further improve the targeting and bioavailability of drugs and achieve more effective treatment. Although the application of click chemistry in vivo still faces challenges such as reaction conditions, biocompatibility and safety, with the development of bioorthogonal reaction systems and the continuous emergence of new reactions, the application potential of click chemistry in the targeted therapy field will continue to expand. In the future, click chemistry is expected to be combined with cutting-edge technologies such as nanomedicine, immunotherapy, and artificial intelligence-assisted drug design to promote personalized and precision medicine to a higher level.

Downloads

Download data is not yet available.

References

[1] Shi J, Fu W, Zou Q, et al. Click Chemistry-Based Nanomaterial Modification for Cancer Targeting: A Review[J]. ACS Applied Nano Materials, 2025.

[2] Jiang X, Hao X, Jing L, et al. Recent applications of click chemistry in drug discovery[J]. Expert opinion on drug discovery, 2019, 14(8): 779-789.

[3] Kumar A, Yadav A K, Mishra V, et al. Recent advancements in triazole-based click chemistry in cancer drug discovery and development[J]. SynOpen, 2023, 7(02): 186-208.

[4] Battigelli A, Almeida B, Shukla A. Recent advances in bioorthogonal click chemistry for biomedical applications[J]. Bioconjugate Chemistry, 2022, 33(2): 263-271.

[5] Devaraj N K, Finn M G. Introduction: click chemistry[J]. Chemical Reviews, 2021, 121(12): 6697-6698.

[6] Surana K R, Jadhav S G, Khiarnar R K, et al. A Recent Concept of Importance: Click Chemistry[J]. Progress in Chemical and Biochemical Research, 2024, 7(4): 394-411.

[7] Rostovtsev V, Green L G, Fokin V V , et al. Angew. Chem. Int. Ed., 2002, 41: 2596 —2599

[8] Breugst M, Reissig H U. The Huisgen reaction: milestones of the 1, 3‐dipolar cycloaddition[J]. Angewandte Chemie International Edition, 2020, 59(30): 12293-12307.

[9] Li Juan, Duan Ming, Zhang Liehui, et al. Click chemistry and its applications[J]. Progress in Chemistry, 2007, 19(11): 1754

[10] Hu X E. Nucleophilic ring opening of aziridines[J]. Tetrahedron, 2004, 60(12): 2701-2743.

[11] Spitaleri G, et al. MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target. Cancers (Basel). 2023;15(19):4779.

[12] Choi H Y, Chang J E. Targeted therapy for cancers: from ongoing clinical trials to FDA-approved drugs[J]. International Journal of Molecular Sciences, 2023, 24(17): 13618.

[13] Paik, P.K.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A.B.; Garassino, M.C.; Mazieres, J.; Viteri, S.; Senellart, H.; Van Meerbeeck, J.; et al. Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. N. Engl. J. Med. 2020, 383, 931–943.

[14] Wolf, J.; Seto, T.; Han, J.-Y.; Reguart, N.; Garon, E.B.; Groen, H.J.M.; Tan, D.S.W.; Hida, T.; de Jonge, M.; Orlov, S.V.; et al. Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer. N. Engl. J. Med. 2020, 383, 944–957.

[15] Colombo F, Tintori C, Furlan A, et al. ‘Click’synthesis of a triazole-based inhibitor of Met functions in cancer cells[J]. Bioorganic & medicinal chemistry letters, 2012, 22(14): 4693-4696.

Downloads

Published

11-10-2025

How to Cite

Zhang, Y. (2025). Advances In The Application Of Click Chemistry In The Research Of Targeted Therapeutic Drugs. Transactions on Materials, Biotechnology and Life Sciences, 8, 377-382. https://doi.org/10.62051/y0yezt68